giant cell arteritis

VF Celebrates Vasculitis Awareness Month 2018

The Vasculitis Foundation, the world’s largest organization dedicated to providing advocacy, education and support for people with vasculitis, announces the launch of Vasculitis Awareness Month (May 2018), an annual effort to create global awareness of the disease that’s so rare that fewer than 200,000 new cases are diagnosed each year.…...

Read more

#GivingTuesday Matching Gift Challenge

#GivingTuesday is a global day of giving fueled by the power of social media and collaboration.  This year your donation can go even further with our generous matching gift challenge! For every dollar donated this year, a special donor will match up to $10,000!  Dollar for dollar! We want to…...

Read more

Introducing our 2017-2018 VCRC-VF Fellow

Kaitlin Quinn, MD, is the recipient of the 2017 VCRC-VF Fellowship.  She received her medical degree from New York Medical College in Valhalla, New York.   She completed her Internal Medicine residency and a two-year Rheumatology fellowship training program at MedStar Georgetown University Hospital in Washington, D.C.  Dr. Quinn is currently…...

Read more

FDA Approves Genentech’s Actemra® for Giant Cell Arteritis

Genentech, a member of the Roche Group, announced today (May 22, 2017) that the U.S. Food and Drug Administration (FDA) has approved Actemra® (tocilizumab) subcutaneous injection for the treatment of GCA, a chronic and severe autoimmune condition. Actemra is the first therapy approved by the FDA for the treatment of…...

Read more

Vasculitis Update 2017 CME Course: Chicago, June 24

The Vasculitis Foundation is pleased to present the 2017 Vasculitis Update CME Course for health care professionals in partnership with Northwestern Division of Rheumatology on Saturday, June 24, 2017 from 7:45 a.m. – 12:30 p.m. at the Marriott Chicago O’Hare.   Topics will include: utilizing biomarkers and imaging in vasculitis, management…...

Read more